Home

Social Media Buzz 6/29/12

Click on a company name to read relevant tweets and blog posts.

The China State Food and Drug Administration (SFDA) has approved 3SBio's application to conduct the China arm of the multi-center Phase III trial of voclosporin.

Aethlon Medical:  Cancer treatment publication authored by Aethlon Medical researchers now available

Aradigm cystic fibrosis drug granted orphan status by FDA.